Neuroprotective Investigation of Chitosan Nanoparticles for Dopamine Delivery-Reference-Cited by-同舟云学术

Neuroprotective Investigation of Chitosan Nanoparticles for Dopamine Delivery

Published:2018-03-21 Issue:4 Volume:8 Page:474
ISSN:2076-3417
Container-title:Applied Sciences
language:en
Short-container-title:Applied Sciences

Author:

Ragusa Andrea,Priore Paola,Giudetti Anna,Ciccarella Giuseppe^ORCID,Gaballo Antonio

Publisher

MDPI AG

Subject

Fluid Flow and Transfer Processes,Computer Science Applications,Process Chemistry and Technology,General Engineering,Instrumentation,General Materials Science

Link

http://www.mdpi.com/2076-3417/8/4/474/pdf

Reference25 articles.

1. Causes of neuronal death in Parkinson’s disease;Schapira;Adv. Neurol.,2001

2. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

3. Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems

4. Glyconanoparticle–DNA Interactions: An Atomic Force Microscopy Study

5. Multiple functionalization of fluorescent nanoparticles for specific biolabeling and drug delivery of dopamine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protective effects of chitosan and curcumin nanoparticles against the hydroxyapatite nanoparticles-induced neurotoxicity in rats;Scientific Reports;2024-09-09

2. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease;Movement Disorders;2024-07-30

3. Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach;Current Diabetes Reviews;2024-05-15

4. Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease;Journal of the Taiwan Institute of Chemical Engineers;2024-04

5. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus;Expert Opinion on Drug Delivery;2024-03-03